Key result
Tocainide treatment exacerbated ventricular arrhythmias in three patients, converting ectopic beats or nonsustained VT to sustained or multimorphic VT.
Why the study?
Does tocainide exacerbate ventricular arrhythmias in patients with pre-existing ventricular arrhythmias?
Case Report (n=3)
Does tocainide exacerbate ventricular arrhythmias in patients with pre-existing ventricular arrhythmias?
Tocainide, a lignocaine-type antiarrhythmic drug, can paradoxically exacerbate ventricular arrhythmias, highlighting the need for careful clinical supervision during therapy.
Answers are grounded in this paper and cite their sources.
Tocainide may worsen ventricular arrhythmias; leaves open proarrhythmic risks of class Ib agents for prospective study.
Exacerbation of ventricular arrhythmias by antiarrhythmic drugs the lignocaine-type has not been reported previously. In this paper we describe three patients with a variety of ventricular arrhythmias who were treated with tocainide and developed worsening of the ventricular arrhythmias. In one patient, frequent ventricular ectopic beats were converted to sustained ventricular tachycardia (VT) in another, nonsustained VT was converted to sustained VT, and in a third, monomorphic VT was converted to multimorphic VT. These patients illustrate the need for careful supervision of antiarrhythmic therapy for VT, even when lignocaine-like drugs are being used.
No takes yet. Share an insight, caveat, or question.
Cheesman et al. (1985) conducted a case report in Ventricular arrhythmias (n=3). Tocainide was evaluated on Exacerbation of ventricular arrhythmias. Tocainide treatment exacerbated ventricular arrhythmias in three patients, converting ectopic beats or nonsustained VT to sustained or multimorphic VT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: